One of the ASX’s leading healthcare stocks has returned to its 52-week highs as investors pile in after its May earnings results.
Fisher & Paykel Healthcare is up over 29 per cent over the last 12 months with its stock hovering close to its 52-week high at $28 per share as of Thursday. Read Post